SKI Market

Indian Indices

Nifty

24,813.45 129.55
(0.52%)

Sensex

80,951.99 -644.64
( -0.79%)

Bank Nifty

55,075.10 197.75
( 0.36%)

Nifty IT

37,540.10 256.60
( 0.69%)

Global Indices

Nasdaq

41,877.63 -820.62
(-1.92%)

Dow Jones

5,865.17 -96.29
(-1.62%)

Hang Seng

37,005.22 -293.76
(-0.79%)

Nikkei 225

8,786.46 5.34
(0.06%)

Forex

USD-INR

85.51 0.08
(0.10%)

EUR-INR

96.26 0.33
(0.35%)

GBP-INR

114.34 0.33
(0.29%)

JPY-INR

0.59 0.00
(0.35%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

152.0404927

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

48.44

15901.14

EPS(TTM)

Face Value()

Div & Yield %

31.38

0.58

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	1016.94	853.17	712.93	616.94	512.33	436.01
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1016.94	853.17	712.93	616.94	512.33	436.01
Other Income	33.78	35.31	23.42	13.81	31.37	17.44
Stock Adjustments	12.08	15.63	23.98	39.05	4.85	1.16
Total Income	1062.80	904.11	760.33	669.80	548.55	454.61
EXPENDITURE :
Raw Materials	241.28	195.84	187.99	150.61	134.79	109.17
Power & Fuel Cost	104.97	97.65	71.64	39.86	37.30	36.29
Employee Cost	123.05	110.28	95.69	69.47	62.24	48.08
Other Manufacturing Expenses	28.00	24.93	17.10	12.99	30.93	12.53
Selling & Administrative Expenses	91.08	82.93	67.90	44.87	31.74	35.72
Miscellaneous Expenses	8.46	13.20	22.66	10.26	15.65	14.90
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	596.83	524.84	462.99	328.05	312.65	256.69
Operating Profit	465.97	379.27	297.34	341.74	235.91	197.92
Interest	3.18	5.18	6.13	1.05	1.17	0.69
Gross Profit	462.79	374.09	291.21	340.69	234.74	197.23
Depreciation	53.59	54.03	50.05	27.52	21.25	19.31
Profit Before Tax	409.20	320.06	241.16	313.17	213.49	177.92
Tax	99.83	79.53	58.49	75.72	54.53	55.62
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.63	2.40	4.10	2.11	-10.00	3.91
Reported Net Profit	304.73	238.13	178.57	235.33	168.96	118.39
Extraordinary Items	10.48	2.70	3.86	5.24	17.47	1.53
Adjusted Net Profit	294.25	235.43	174.71	230.09	151.49	116.86
Adjustment below Net Profit	-0.01	0.26	-0.56	-0.04	-0.84	0.14
P & L Balance brought forward	1170.33	985.51	878.02	648.43	560.85	472.71
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	71.45	53.56	70.52	5.71	80.55	30.38
P & L Balance carried down	1403.60	1170.33	985.51	878.02	648.43	560.85
Dividend	0.00	0.00	0.00	0.00	0.00	25.20
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	875.00	683.00	51.20	0.00	392.50	264.50
Dividend Per Share(Rs)	8.75	6.83	5.12	0.00	39.25	26.45
Earnings Per Share-Unit Curr	29.13	22.76	187.76	247.44	177.66	124.48
Earnings Per Share(Adj)-Unit Curr	29.13	22.76	187.76	247.44	177.66	124.48
Book Value-Unit Curr	145.80	123.50	1164.13	1051.11	809.71	717.62
Book Value(Adj)-Unit Curr	145.80	123.50	1164.13	1051.11	809.71	717.62

24,813.45 129.55 (0.52%)

80,951.99 -644.64 ( -0.79%)

55,075.10 197.75 ( 0.36%)

37,540.10 256.60 ( 0.69%)

41,877.63 -820.62 (-1.92%)

5,865.17 -96.29 (-1.62%)

37,005.22 -293.76 (-0.79%)

8,786.46 5.34 (0.06%)

85.51 0.08 (0.10%)

96.26 0.33 (0.35%)

114.34 0.33 (0.29%)

0.59 0.00 (0.35%)